News

Media contact:
Molly Bowen  |  410-955-9948

We Are Weill Cornell Medicine: Dr. Jyoti Mathad

Post Date: 
2018-05-18
Dr. Jyoti Mathad
Video by Weill Cornell Medicine features Jyoti Mathad and her work with the Indo-JHU Clinical Research Partnership.

Shah Receives Dr. David Glasser Memorial Award for TB Control in Maryland

Post Date: 
2018-04-27
Dr. Maunank Shah
Award recognizes significant contributions to tuberculosis prevention & control in MD.

World Tuberculosis (TB) Day Recognized with Community Event at BJGMC

Post Date: 
2018-04-17
World Health Day group activities at BJGMC Clinical Research Site in Pune, India
This year's themes: Maintaining healthy nutrition, addressing mental heatlh challenges, and the latest in TB research.

Tornheim Receives W. Leigh Thompson Excellence in Research Award

Post Date: 
2018-03-21
Dr. Jeffrey Tornheim
Jeff Tornheim's research on drug-resistant tuberculosis in India garners high honors from Johns Hopkins Department of Medicine.

CCGHE at CROI 2018

Post Date: 
2018-03-05
Check out where and when CCGHE presented at the Conference on Retroviruses and Opportunistic Infections. One Month of Rifapentine/Isoniazid to Prevent TB In People With HIV: Brief-TB/A5279 Swindells S, Ramchandani R, Gupta A, Benson CA, Leon-Cruz JT, Omoz-Oarhe A, Juste MAJ, Lama JR, Valencia JA,...

2017 Year in Review

Post Date: 
2018-02-19
What a year! Our 2017 Year In Review outlines the most ambitious 365 days we’ve had to date.

Uniting for a Healthier India

Post Date: 
2018-02-14
Uniting India slide
"The Indo-US clinical research & education partnership started with a single NIH grant to study maternal-infant HIV transmission." Now with 76 studies underway, this short film chronicles the history & impact of our work in India.

World AIDS Day: BJGMC Team Offers Community Counseling and Preventive Care

Post Date: 
2017-12-21
150 people participated in a non-communicable diseases awareness camp for people in Pune, India, living with HIV.

CCGHE Joins 12-Country UNITAID Effort to Control TB

Post Date: 
2017-11-08
Shorter course to prevent progression of latent TB to active disease is the aim of the effort.

CCGHE at the Union 2017

Post Date: 
2017-10-05
The 2017 Union Conference was in Guadalajaro, Mexico, October 11-14, and Indo-JHU research was well represented.

ID Clinical Minute is Back and Offering CME Credit!

Post Date: 
2017-10-03
Issues will be published bimonthly and CME will be available through ACCME

Tornheim Promoted to Assistant Professor

Post Date: 
2017-08-31
His research explores whether 2 MDR-TB drug susceptibility tests using WGS & MIC can yield options for individualized treament.

Indo-Hopkins Partnership Seeks Causes of Sepsis in the NICU

Post Date: 
2017-08-10
Sepsis among newborns in the neonatal intensive care unit (NICU) is a big problem in India, and a complex one to untangle.

Vidya Mave Promoted to Assistant Professor

Post Date: 
2017-06-06
Dr. Vidya Mave oversees clinical research & visiting researchers in India, including students conducting global health field studies

CCGHE at ATS 2017

Post Date: 
2017-05-08
Abstract presentations from the American Thoracic Society International Conference in Washington, DC

Amita Gupta and colleagues discuss female leadership in academic global health

Post Date: 
2017-05-04
Drs. Gupta, Manabe, Mathad discuss need for more women in global health leadership at CUGH's annual meeting.

Women's Empowerment at BJGMC World TB Day 2017

Post Date: 
2017-04-03
Posted 2017-04-03

Health on the Go: Mobile Clinic Delivers TB Services at Point of Need

Post Date: 
2017-03-24
Thanks to Raj and Bharti Shah, CTIS, & the NB Shah Charitable Trust, we are able to reach more people in Maharashtra who need care

CCGHE at CROI 2017

Post Date: 
2017-02-02
Inflammation biomarkers, hepatoxicity during ART and IRT, TB treatment adherence--just some of the abstracts presented at CROI

Global Impact Report

Post Date: 
2017-01-31
Learn about CCGHE's work to improve infectious disease prevention & treatment around the world.

Pages

Infectious Diseases Can Be Tackled, Here are 3 Solutions

Post Date: 
2018-05-09
Source: 
The Hill
The Hill: OpEd by Dr. Bob Bollinger: During epidemics, time is of the essence. Quick delivery of care to sick patients eases the human impact and lowers the cost of disease.

Isoniazid preventive therapy: do the risks outweigh the benefits in pregnant women with HIV?

Post Date: 
2018-03-13
Source: 
aidsmap
. . . Isoniazid preventive therapy (IPT) during and after pregnancy in women living with HIV on antiretroviral therapy (ART) in tuberculosis (TB) endemic areas in Africa, Asia and Haiti resulted in serious adverse events quite possibly attributable to isoniazid with no significant reduction in TB...

Adverse pregnancy outcomes with isoniazid preventive therapy in HIV

Post Date: 
2018-03-09
Source: 
Infectious Disease Advisor
. . . The safety of IPT in pregnant women with HIV is unknown, especially with regard to its combination with highly active antiretroviral therapy (ART). Amita Gupta, MD, deputy director of the Johns Hopkins University Center for Clinical Global Health Education at the Johns Hopkins University...

No difference in safety for HIV+ pregnant women deferring TB Tx

Post Date: 
2018-03-09
Source: 
MedPage Today
MedPage Today
First randomized clinical trail of IPT in pregnant and postpartum women may suggest need for WHO guideline change.

Preventive TB therapy during pregnancy causes excessive adverse events

Post Date: 
2018-03-08
Source: 
Healio Infectious Disease News
. . . “Identifying ways to prevent TB during pregnancy and the postpartum period is a really important way to address maternal and infant health for a globally important disease such as tuberculosis,” Amita Gupta, MD, MHS, associate professor of medicine and international health and deputy director...

Study Results for IMPAACT P1078 Presented at CROI 2018

Post Date: 
2018-03-07
Source: 
IMPAACT Network News
IMPAACT Network News: Dr. Amita Gupta presented findings at CROI 2018.

TB medication adherence rates up, thanks to smartphone app

Post Date: 
2018-03-02
Source: 
YourCentralValley.com (Fresno, CA)
Emocha's app is helping tuberculosis patients in Fresno County stick to their treatment plans.

WHO sets disease priorities for 2018; Tuberculosis once again not included

Post Date: 
2018-02-15
Source: 
Contagion Live: Infectious Diseases Today
CCGHE Director Bob Bollinger weighs in on WHO's priority pathogens for 2018.

The Health App that Beat Hurricane Harvey

Post Date: 
2018-01-18
Source: 
Politico
CCGHE invented the emocha Mobile Health platform, and it's changing the way tuberculosis patients are cared for.

In-Depth: How digital health technologies can help the United States address the opioid epidemic

Post Date: 
2018-01-05
Source: 
MobiHealthNews
Bob Bollinger interviewed about utility of mobile health in keeping patients connected to care.

Notes from the Field: Use of Asynchronous Video Directly Observed Therapy for Treatment of Tuberculosis and Latent Tuberculosis Infection in a Long-Term–Care Facility ― Puerto Rico, 2016–2017

Post Date: 
2017-12-22
Source: 
Morbidity and Mortality Weekly Report
emocha's video Directly Observed Therapy is highlighted in this report.

Notes from the Field--Tuberculosis Control Activities After Hurricane Harvey--Texas, 2017

Post Date: 
2017-12-15
Source: 
Morbidity and Mortality Weekly Report
emocha's video Directly Observed Therapy helped officials maintain continuity of care for TB patients following Hurricane Harvey.

Upstarts: A Better Blood Test?

Post Date: 
2017-12-15
Source: 
JHU Engineering Impact
The miLAB handheld diagnostic project led by Dr. Bob Bollinger is the feature of this report.

Celebrating Johns Hopkins Medicine's impact in India

Post Date: 
2017-12-13
Source: 
The Campaign for Johns Hopkins Medicine
In 4 years, the CCGHE has tripled its capacity for conducting research on grave health threats, thanks to strong philanthropic support.

Transforming India from TB Hot Zone to TB Hot Shot

Post Date: 
2017-12-09
Source: 
Indiaspora
Dr. Amita Gupta's invited commentary: Can Indian transform its role in the global TB epidemic?

4 ways that telemedicine can address the opioid crisis

Post Date: 
2017-12-01
Source: 
The Hill
CCGHE Director Dr. Bob Bollinger describes the utility of telemedicine in this opinion article in The Hill.

Combination HIV prevention reduces infections

Post Date: 
2017-12-01
Source: 
MD Magazine
. . . Researchers found that throughout the 7-year period in which rates of treatment and voluntary medical male circumcision increased significantly, HIV incidence dropped by 42% among nearly 18,000 people in Uganda . . .

Male circumcision and antiviral drugs appear to sharply reduce HIV infection rate

Post Date: 
2017-11-29
Source: 
Medical Xpress
. . . The current study, based on RCCS data on 34,000 adults enrolled and followed between 1989 and 2016, confirmed the widespread adoption of many of PEPFAR's HIV prevention measures. The use of antiretroviral therapy among infected people rose steadily from 12 percent in the 2006 survey to 69...

Toward a TB-Free India

Post Date: 
2017-11-09
Source: 
Interagency TB Newsletter
TB research underway by the Indo-JHU clinical research partnership is highlighted in the US Interagency TB Newsletter.

Mexico conference: Experts from BJ Medical College make presentations on TB, treatment

Post Date: 
2017-11-09
Source: 
The Indian Express
Four fellows from the BJGMC-JHU Fogarty HIV-TB Training Program make national headlines in India.

Pages

Smartphone App Keeps an ‘Eye’ on Daily Tuberculosis Therapy

Post Date: 
2018-04-26
Johns Hopkins Medicine logo
Study shows success with TB therapy observation conducted via video instead of via in-person clinic visits.

One-Month Tuberculosis Prophylaxis as Effective as Nine-Month Regimen for People Living with HIV

Post Date: 
2018-03-05
NIH Logo
The Indo-JHU Clinical Research Partnership participated in this important study that could change TB prevention for people living with HIV.

Tip Sheet: Johns Hopkins Researchers Present at Annual CROI Meeting

Post Date: 
2018-03-01
Newswise — Amita Gupta, M.D., deputy director of the Johns Hopkins University Center for Clinical Global Health Education at the Johns Hopkins University School of Medicine, will present a multicounty study of preventive treatment for tuberculosis (TB) in HIV-infected pregnant and postpartum women—...

emocha Named to 2018 Top 10 Most Innovative Companies in Health by Fast Company

Post Date: 
2018-02-20
The Most Innovative Companies list recognizes pioneering companies across 36 categories, from health to artificial intelligence to wellness.

NIH Statement on World AIDS Day 2017

Post Date: 
2017-12-01
. . . A study published recently in the New England Journal of Medicine found that HIV incidence dropped by 42 percent among nearly 18,000 people in a Ugandan district during a 7-year period when the rates of HIV treatment and voluntary medical male circumcision were significantly increased . . .

Combination HIV Prevention Reduces New Infections by 42 Percent in Ugandan District

Post Date: 
2017-11-29
NIH announces findings from Larry Chang and colleagues published in the New England Journal of Medicine .

Male Circumcision and Antiviral Drugs Appear to Sharply Reduce HIV Infection Rate

Post Date: 
2017-11-29
. . . The study, published Nov. 29 in the New England Journal of Medicine , is the first to track a large group of people before, during and after the start of an HIV prevention program and show that the program is likely working on a large scale. The researchers found that as the program began and...

Mobile Health and Wellness Clinic Debuts in Pune for Clinical Research and Community-Based Care

Post Date: 
2016-07-25
The Maryland-based health care informatics company CTIS and its founders, Raj and Bharti Shah, have collaborated with the Johns Hopkins Center for Clinical Global Health Education and Byramjee Jeejeebhoy Government Medical College to equip and dispatch a custom-designed mobile health care services...

Proactively treating HIV patients at risk for tuberculosis with multidrug TB therapy doesn’t save more lives

Post Date: 
2016-03-17
In what investigators say is a surprise finding, results of a new study appear to strongly affirm the effectiveness of prescribing the anti-tuberculosis drug isoniazid alone — in place of the standard four-drug regimen — to prevent TB and reduce death in people with advanced HIV/AIDS infections...